Onyda XR 0.1 mg/mL extended-release oral suspension Images
Generic Name: clonidine
This medication has been identified as Onyda XR 0.1 mg/mL extended-release oral suspension. It is supplied by NextWave Pharmaceuticals, Inc.
Onyda XR is used in the treatment of ADHD and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy. Onyda XR 0.1 mg/mL extended-release oral suspension is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Onyda XR
- Generic Name
- clonidine
- Strength
- 0.1 mg/mL extended-release oral suspension
- Availability
- Prescription only
- Drug Class
- Antiadrenergic agents, centrally acting
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- NextWave Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 24478-0148
See also:
More about Onyda XR (clonidine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiadrenergic agents, centrally acting
- Breastfeeding
Patient resources
Other brands
Catapres, Kapvay, Catapres-TTS, Duraclon, Nexiclon XR
Professional resources
Other brands
Catapres, Kapvay, Catapres-TTS, Duraclon, Nexiclon XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.